Publications by the researcher in collaboration with Marta González Alvarez (40)

2024

  1. In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug

    Pharmaceutics, Vol. 16, Núm. 3

  2. Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole

    Pharmaceutics, Vol. 16, Núm. 5

2022

  1. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen

    International Journal of Pharmaceutics, Vol. 614

2020

  1. Candesartan cilexetil in vitro–in vivo correlation: Predictive dissolution as a development tool

    Pharmaceutics, Vol. 12, Núm. 7, pp. 1-21

  2. New insights of oral colonic drug delivery systems for inflammatory bowel disease therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-30

2019

  1. Covalently crosslinked organophosphorous derivatives-chitosan hydrogel as a drug delivery system for oral administration of camptothecin

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 136, pp. 174-183

  2. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease

    Molecular Pharmaceutics, Vol. 16, Núm. 6, pp. 2418-2429

  3. Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug

    International Journal of Pharmaceutics, Vol. 557, pp. 36-42

2018

  1. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat—Biophysical Model and Predictions Based on Caco-2

    Pharmaceutical Research, Vol. 35, Núm. 1

  2. Functional magnetic mesoporous silica microparticles capped with an azo-derivative: A promising colon drug delivery device

    Molecules, Vol. 23, Núm. 2

  3. Ionic Hydrogel Based on Chitosan Cross-Linked with 6-Phosphogluconic Trisodium Salt as a Drug Delivery System

    Biomacromolecules, Vol. 19, Núm. 4, pp. 1294-1304

  4. Long-circulating hyaluronan-based nanohydrogels as carriers of hydrophobic drugs

    Pharmaceutics, Vol. 10, Núm. 4

  5. PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen

    European Journal of Pharmaceutical Sciences, Vol. 115, pp. 119-125

  6. Preclinical models for colonic absorption, application to controlled release formulation development

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 130, pp. 247-259

  7. Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment

    Journal of Controlled Release, Vol. 281, pp. 58-69

2017

  1. Enhancing Oral Absorption of β-Lapachone: Progress Till Date

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 42, Núm. 1

  2. Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion

    International Journal of Pharmaceutics, Vol. 527, Núm. 1-2, pp. 135-141

  3. Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B coculture models to predict intestinal and colonic permeability compared to Caco-2 monoculture

    Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1264-1270

2016

  1. Development of an ion-pair to improve the colon permeability of a low permeability drug: Atenolol

    European Journal of Pharmaceutical Sciences, Vol. 93, pp. 334-340

  2. Importance and applications of cell-and tissue-based in vitro models for drug permeability screening in early stages of drug development

    Concepts and Models for Drug Permeability Studies: Cell and Tissue based In Vitro Culture Models (Elsevier Inc.), pp. 3-29